Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

NCT00509899 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis
Polycythemia Vera
Thrombocytosis

Interventions

DRUG: Ruxolitinib

Sponsor

Incyte Corporation